Yukari Kamijima

407 citations
8 papers · 307 indexed · h-index 6
Topics
Diabetes Treatment and Management (2 papers)Blood Pressure and Hypertension Studies (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)
Partner nations
JapanUnited StatesTaiwan

In The Last Decade

Yukari Kamijima

7 papers receiving 304 citations

Peers

Yukari Kamijima
Comparison fields: 5 of 66
  • Immunology 194
  • Dermatology 130
  • Rheumatology 59
  • Physiology 52
  • Pathology and Forensic Medicine 48
Replace Canelle Mazaud with:
Canelle Mazaud France
Jackie Lu United States
Laëtitia Penso France
Jill Parnham United Kingdom
Jorge Puelles United States
Matthew T. Taylor United States
Aparna Sajja United States
Helena Kastarinen Finland
Caroline C. Horner United States
David R. Carr United States
Yukari Kamijima relative to Canelle Mazaud France Canelle Mazaud's profile →
Citations per field
00.5×10.5×
Canelle Mazaud · 1×
Citations per year

Countries citing papers authored by Yukari Kamijima

Since Specialization
Citations

This map shows the geographic impact of Yukari Kamijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukari Kamijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukari Kamijima more than expected).

Fields of papers citing papers by Yukari Kamijima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukari Kamijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukari Kamijima. The network helps show where Yukari Kamijima may publish in the future.

Co-authorship network of co-authors of Yukari Kamijima

This figure shows the co-authorship network connecting the top 25 collaborators of Yukari Kamijima. A scholar is included among the top collaborators of Yukari Kamijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukari Kamijima. Yukari Kamijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 20
3 9
4 9
5 20
6 238
7 3
8 8

About Yukari Kamijima

Yukari Kamijima is a scholar working on Toxicology, Internal Medicine and Gastroenterology, having authored 8 papers that have together received 307 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (2 papers), Blood Pressure and Hypertension Studies (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Dermatology (130 citations), Immunology (194 citations) and Rheumatology (59 citations). Yukari Kamijima has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Kiyoshi Kubota, Nobuhiro Ooba, Daisuke Koide, Tsugumichi Sato, Hidemi Nakagawa, Hajime Iizuka, Kenneth K. C. Man, Martijn J. Schuemie, Ian Chi Kei Wong and Shinya Kimura. Their work appears in journals such as PLoS ONE, Journal of Psychiatric Research and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026